{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "country": "United States",
      "city": "Oklahoma City",
      "address_1": "727 N Ann Arbor Ave",
      "reason_for_recall": "CGMP deviations.",
      "address_2": "",
      "product_quantity": "7174 bottles",
      "code_info": "Lots: K16E92 Exp. 5/31/18; B17A87 Exp. 5/31/18; E17A51 Exp. 5/31/18; L16B59 Exp. 1/31/18; K16E01 Exp. 5/31/18; A17F21 Exp. 5/31/18; B17D71 Exp. 5/31/18; D17E92 Exp. 5/31/18; J16D13 Exp. 1/31/18; A17D63 Exp. 5/31/18; E17A18 Exp. 5/31/18; F17B87 Exp. 5/31/18; C17C58 Exp. 5/31/18",
      "center_classification_date": "20180208",
      "distribution_pattern": "Nationwide",
      "state": "OK",
      "product_description": "PD-Rx Pharmaceuticals Incorporated Ibuprofen 200 mg tablets a) 24 tablets NDC 55289-673-24; b) 30 tablets NDC 55289-673-30; c) 50 tablets NDC 55289-673-50; d) 60 tablets NDC 55289-673-60",
      "report_date": "20180207",
      "classification": "Class II",
      "openfda": {},
      "recalling_firm": "PD-Rx Pharmaceuticals, Inc.",
      "recall_number": "D-0341-2018",
      "initial_firm_notification": "Letter",
      "product_type": "Drugs",
      "event_id": "79023",
      "termination_date": "20200507",
      "more_code_info": "",
      "recall_initiation_date": "20180125",
      "postal_code": "73127-5822",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "status": "Terminated"
    }
  ]
}